Mark Schmidt to Genotype
This is a "connection" page, showing publications Mark Schmidt has written about Genotype.
Connection Strength
0.057
-
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis?C and Cirrhosis. Adv Ther. 2024 Feb; 41(2):744-758.
Score: 0.057